Administrative Core
Administrative Core
批准号:
10473850
负责人:
Monica Kraft
金额:
$15.69万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
未结题
起止时间:
2016-06-01 至 2026-05-31
关键词:
2019-nCoVAdherenceAdvisory CommitteesAllergic DiseaseAnionsArizonaAsthmaAttenuatedBiologicalBiological Response ModifiersCollaborationsCollectionCommunicationCommunitiesDataData AnalysesEnsureEthicsFosteringFunding OpportunitiesFutureGrantGuidelinesHealthHuman ResourcesImmuneImmune responseImmunologic FactorsImmunomodulatorsInfectionInflammationInflammatory ResponseInfluenza A virusInformation DisseminationInfrastructureInstitutionLipidsMediator of activation proteinMedical centerMolecularMonitorNatural ImmunityParticipantPerformancePhosphatidylglycerolsPhosphatidylinositolsProgram ReviewsPublicationsPulmonary Surfactant-Associated Protein ARecording of previous eventsRegulationResearchResearch ActivityResearch PersonnelResourcesRoleSamplingScheduleShippingTOLLIP geneTimeTranslatingTravelUnited States National Institutes of HealthUniversitiesVertebratesViralVirus DiseasesVisionWorkasthma exacerbationbaseclinical practiceconflict resolutioncostdata managementfollower of religion Jewishhuman subjectinnate immune mechanismsmeetingsmembernovel therapeuticsoperationprogramssuccesssurfactantsymposiumsynergism
中文摘要
这个U19哮喘和过敏性疾病合作研究中心(AACDRC)计划汇集了
一个研究小组在三个互动项目和两个核心,重点放在特定的先天性
病毒感染和哮喘的免疫机制。在更新我们的AADCRC计划时,我们将继续
为了关注关键的且经常未被充分研究的先天免疫因子表面活性蛋白-A(SP-A),
表面活性剂阴离子脂质(棕榈酰-油酰-磷脂酰甘油(POPG)和磷脂酰肌醇(PI))
和Toll相互作用蛋白(Tollip),一种先天免疫介质,已知与SP-A和免疫球蛋白相互作用。
阴离子脂质。这些介质中的每一种协同作用以调节炎症和免疫反应。
哮喘和感染的反应,因为它们的互补功能。我们令人兴奋的初步数据支持
我们项目的总体假设是POPG/PI、Tollip和SP-A作为独特的免疫调节剂发挥作用
减弱特定病毒感染(RV-C、甲型流感和SARS-CoV-2)对2型
哮喘该项目的研究人员在美国有着悠久的合作历史。亚利桑那大学和
国家犹太健康;雪松西奈医疗中心现在包括在这次更新。行政核心
(Core A)本计划将发挥重要作用,以保持富有成效和充满活力的合作,确保
跟踪对NIH和其他相关法规和指南的遵守情况,并管理将
继续加强围绕该计划的研究社区。行政核心具有
(1)管理日常行政细节和方案需要,
AADCRC计划通过提供财政管理,管理分包合同,确保监管
(2)建立基础设施,
促进项目、核心和。研究人员和NIH项目主任,
在必要时提供冲突解决办法;(3)协助及时传播研究成果,
时尚的科学界,无论是在地方和国家,并提供信息给公众,包括
研究参与者; 4)为AADCRC实施基础设施和机会基金。我们的建议是
在我们20多年的积极和富有成效的合作,并将大大提高我们的理解
2型炎症和病毒感染之间相互作用的内在分子机制
哮喘恶化。我们的项目之间的强大协同作用将加速向新的进展
通过证明研究中的先天免疫成分可以保护免受病毒感染,
哮喘的感染
英文摘要
This U19 Asthma and Allergic Diseases Cooperative Research Center (AACDRC) Program brings together a
team of investigators in three interactive projects and two cores to focus on the pathobiology of specific innate
immune mechanisms in viral infection and asthma. In the renewal of our AADCRC program, we will continue
to focus on the critical and often understudied innate immune factors surfactant protein-A (SP-A), the
anion lipids of surfactant, (palmitoyl-oleoyl-phosphatidylglycerol (POPG) and phosphatidylinositol (PI))
and Toll interacting protein (Tollip), an innate immune mediator known to cross talk with SP-A and the
anionic lipids. Each of these mediators works synergistically to modulate inflammatory and immunologic
responses in asthma and infection given their complementary functions. Our exciting preliminary data underpin
our program’s overall hypothesis that POPG/PI, Tollip and SP-A function as unique immune modulators
that attenuate the impact of specific viral infections (RV-C, Influenza A and SARS-CoV-2) in type-2
asthma. The investigators in this program have a long history of collaboration at the. University of Arizona and
National Jewish Health; Cedar Sinai Medical Center is now included in this renewal. The Administrative Core
(Core A) of this Program will perform an important role to maintain productive and vibrant collaboration, ensure
and track adherence to NIH and other relevant regulations and guidelines, and manage activities that will
continue to strengthen the research community surrounding this Program. The Administrative Core has the
following Specific Aims: (1) Manage the day-to-day administrative details and programmatic needs of the
AADCRC program by providing fiscal management, administering subcontracts, assuring that regulatory
requirements in are met, and monitoring of progress with program objectives; (2) Create an infrastructure to
facilitate communication between the projects, cores and. investigators, and NIH Program Directors and to
provide conflict resolution should it be necessary; (3) Assist with dissemination of research findings in a timely
fashion to the scientific community, both locally and nationally, and provide information to the public, including
study participants; 4) Implement the Infrastructure and Opportunity Fund for the AADCRC. Our proposal builds
upon our active and productive collaborations of over 20 years and will significantly enhance our understanding
of the innate molecular mechanisms underlying the interaction between type 2 inflammation in and viral
exacerbations of asthma. The strong synergy among our projects will accelerate progress toward novel
therapies by demonstrating that the innate immune components under study protect against viral
infection in asthma.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The Duke Senescent Cell Evaluations in Normal Tissues (SCENT) Mapping Center
-
批准号:10689774
-
项目类别:
-
资助金额:$254.73万
-
财政年份:2021
-
负责人:Monica Kraft
-
依托单位:
The Immunophenotyping Assessment in a COVID-19 Cohort (IMPACC)
-
批准号:10204632
-
项目类别:
-
资助金额:$56.13万
-
财政年份:2020
-
负责人:Monica Kraft
-
依托单位:
Clinical Core
-
批准号:10216759
-
项目类别:
-
资助金额:$56.13万
-
财政年份:2020
-
负责人:Monica Kraft
-
依托单位:
University of Arizona-Banner Health All of Us Research Program
-
批准号:10338519
-
项目类别:
-
资助金额:$1150.0万
-
财政年份:2018
-
负责人:Monica Kraft
-
依托单位:
Surfactant Protein-A and Type 2 Asthma in SARS-CoV-2 Infection
-
批准号:10661671
-
项目类别:
-
资助金额:$46.95万
-
财政年份:2016
-
负责人:Monica Kraft
-
依托单位:
Administrative Core
-
批准号:10261953
-
项目类别:
-
资助金额:$14.68万
-
财政年份:2016
-
负责人:Monica Kraft
-
依托单位:
Innate Immunity and Viral Infection in Asthma
-
批准号:10473849
-
项目类别:
-
资助金额:$143.16万
-
财政年份:2016
-
负责人:Monica Kraft
-
依托单位:
Surfactant Protein-A and Type 2 Asthma in SARS-CoV-2 Infection
-
批准号:10261957
-
项目类别:
-
资助金额:$37.12万
-
财政年份:2016
-
负责人:Monica Kraft
-
依托单位:
Surfactant Protein-A and Type 2 Asthma in SARS-CoV-2 Infection
-
批准号:10473864
-
项目类别:
-
资助金额:$45.08万
-
财政年份:2016
-
负责人:Monica Kraft
-
依托单位:
Dysfunction of Innate Immunity in Asthma
-
批准号:9156365
-
项目类别:
-
资助金额:$142.82万
-
财政年份:2016
-
负责人:Monica Kraft
-
依托单位:
Innate Immunity and Viral Infection in Asthma
-
批准号:10661638
-
项目类别:
-
资助金额:$143.16万
-
财政年份:2016
-
负责人:Monica Kraft
-
依托单位:
Innate Immunity and Viral Infection in Asthma
-
批准号:10261952
-
项目类别:
-
资助金额:$143.35万
-
财政年份:2016
-
负责人:Monica Kraft
-
依托单位:
Dysfunction of Innate Immunity in Asthma
-
批准号:9305026
-
项目类别:
-
资助金额:$140.15万
-
财政年份:2016
-
负责人:Monica Kraft
-
依托单位:
Administrative Core
-
批准号:10661660
-
项目类别:
-
资助金额:$20.54万
-
财政年份:2016
-
负责人:Monica Kraft
-
依托单位:
58th Annual Aspen Lung Conference
-
批准号:8910993
-
项目类别:
-
资助金额:$2.0万
-
财政年份:2015
-
负责人:Monica Kraft
-
依托单位:
Host Factors in Regulation of Inflammatory and Fibroproliferative Lung Disease
-
批准号:8337988
-
项目类别:
-
资助金额:$200.93万
-
财政年份:2012
-
负责人:Monica Kraft
-
依托单位:
Arizona/Duke Clinical Center for AsthmaNet
-
批准号:7936922
-
项目类别:
-
资助金额:$86.26万
-
财政年份:2009
-
负责人:Monica Kraft
-
依托单位:
Airway Remondeling in Asthma: Modulation By IL-13
-
批准号:7917408
-
项目类别:
-
资助金额:$44.84万
-
财政年份:2009
-
负责人:Monica Kraft
-
依托单位:
Administrative Core
-
批准号:8325219
-
项目类别:
-
资助金额:$18.25万
-
财政年份:2009
-
负责人:Monica Kraft
-
依托单位:
SP-A as an immune modulator
-
批准号:8321464
-
项目类别:
-
资助金额:$142.92万
-
财政年份:2009
-
负责人:Monica Kraft
-
依托单位:
海外基金